GSK Announces New Product Labels For Serevent® And Advair®

... GlaxoSmithKline today announced that it has agreed with the U.S. Food and Drug Administration on product labeling for its respiratory products Serevent® Diskus® and Advair Diskus®. The agreement concludes ongoing discussions between GSK and FDA following an earlier advisory committee meeting about the safety of long-acting beta2-agonists, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair... click link for more info. ...